Skip to main content
. 2020 Nov 24;12(12):3497. doi: 10.3390/cancers12123497

Figure 1.

Figure 1

Multiparametric and dynamic model to consider the best treatment choice for one patient. MM: multiple myeloma, PCL: plasma cell leukemia, ED: extramedullary disease, MRD: minimal residual disease, QoL: quality of life, AE: adverse events.